Operationally, performance was mixed. EBIT came in at ₹1,709.4 crore, slightly above estimates, but margins contracted to 15.1% from 16.1% in the previous quarter, missing expectations of 15.2%.
Management flagged strong deal momentum and a healthy pipeline. CEO & MD Venu Lambu said the company has accelerated its shift to an AI-led model, backed by its BlueVerse platform and large-scale talent transformation. He added that efficiencies from the Fit4Future programme and continued large deal wins are strengthening its “Business Creativity” positioning.LTM FY26 results
For FY26, revenue stood at ₹42,307.6 crore, while net profit came in at ₹4,982.7 crore. The board recommended a final dividend of ₹53 per share, subject to shareholder approval.
Management had earlier indicated that wage hikes would be spread across the March and June quarters, with an estimated 100 basis points impact in each quarter, partly offset by operational efficiencies.Also read: Himadri Speciality Q4 Results | Net profit surges 29% on higher revenue; declares dividend
The company continues to target improved margins over FY26, supported by its “Fit for Future” programme, though analysts believe the journey toward the 17–18% margin band may take time.
On the demand front, the BFSI vertical is expected to stabilise after recent headwinds, while segments such as hi-tech and healthcare are likely to drive growth. Order inflows are expected to remain steady, with large deal ramp-ups, including government-led projects, being closely tracked by investors.
The Street will also watch commentary on the sustainability of the company’s growth trajectory, especially amid some near-term uncertainty due to billing deferments in the Middle East and global macro headwinds.
Shares of the company closed nearly 2% lower ahead of the Q4 earnings result announcement on Thursday, at ₹4,514.40. The stock has gained almost 10% over the last month.
Also read: Balrampur Chini to raise ₹450 crore via preferential issue; hikes PLA capex
